Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cellular Biomedicine Group Inc (NASDAQ:CBMG)

9.60
Delayed Data
As of Oct 20
 0.00 / 0.00%
Today’s Change
5.05
Today|||52-Week Range
15.45
-26.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues4.1M564.4K2.5M627.9K
 
 
 
 
 
Cost of Goods Sold763.5K213.2K833.0K860.4K
 
 
 
 
 
Depreciation And Amortization841.2K1.2M2.1M2.6M
 
 
 
 
 
 
Operating ExpensesGross Income2.5M-839.4K-422.2K-2.9M
 
 
 
 
 
General Expenses11.3M10.2M20.3M20.9M
 
 
 
 
 
Research And Development1.9M2.7M7.6M11.5M
 
 
 
 
 
Total Operating Expenses12.9M11.6M23.2M24.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.9M-11.0M-20.7M-23.8M
 
 
 
 
 
Extraordinary Charge-4.3M-1.4M-123.4K-4.6M
 
 
 
 
 
Interest Expense On Debt257.8K0.000.000.00
 
 
Other Expenses-71.5K72.0K630.4K54.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.5M-12.4M-20.2M-28.2M
 
 
 
 
 
Income Taxes-344.4K0.00-728.6K-4.1K
 
 
 
 
Discontinued Operations0.00-3.1M0.000.00
 
 
Net Income-13.8M-15.5M-19.4M-28.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.8M8.6M11.5M13.5M
 
 
 
 
 
Shares To Calculate EPS Diluted5.8M8.6M11.5M13.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.38-$1.79-$1.70-$2.09
 
 
 
 
 
EPS Diluted-$2.38-$1.79-$1.70-$2.09